← All Fractyl Health, INC filings

Fractyl Health, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
GUTS
Fractyl Health, INC
10-K: Fractyl Health Faces Going Concern Doubt Amidst Strategic Shift
Fractyl Health, a clinical-stage metabolic therapeutics company, reported significant net losses and raised substantial doubt about its ability to continue as a going concern, despite advancing its Revita and Rejuva product candidates.
NASDAQ
GUTS
Fractyl Health, INC
10-K: Fractyl Health Prioritizes Weight Loss Program, Pauses T2D Efforts in Strategic Shift
Fractyl Health refocuses on its weight loss maintenance program after positive preliminary results, pausing investment in its type 2 diabetes initiatives.
NASDAQ
GUTS
Fractyl Health, INC
10-K: Fractyl Health Outlines Capital Structure and Growth Strategy in 10-K Filing
Fractyl Health's 10-K filing details its capital structure, registration rights, and strategic focus on developing therapies for metabolic diseases.